UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD)

Q3 2021 13F Holders as of 9/30/2021

Type / Class
Equity / Common Shares
Shares outstanding
3.2M
Number of holders
71
Total 13F shares, excl. options
2.6M
Shares change
+1.74K
Total reported value, excl. options
$241M
Value change
+$234K
Number of buys
28
Number of sells
-26
Price
$92.83

Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q3 2021

74 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q3 2021.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.6M shares of 3.2M outstanding shares and own 81.2% of the company stock.
Largest 10 shareholders include FMR LLC (497K shares), PRICE T ROWE ASSOCIATES INC /MD/ (281K shares), RENAISSANCE TECHNOLOGIES LLC (230K shares), BlackRock Inc. (216K shares), VANGUARD GROUP INC (216K shares), DIMENSIONAL FUND ADVISORS LP (152K shares), RICE HALL JAMES & ASSOCIATES, LLC (115K shares), JPMORGAN CHASE & CO (93.7K shares), Russell Investments Group, Ltd. (76.8K shares), and Ranger Investment Management, L.P. (68.7K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.